| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |